Real-world study in type 2 diabetes suggests possible association, but more research is ne ...

The initiation of GLP-1 agonists was associated with a lower risk for Alzheimer’s disease and related dementias than the initiation of DPP-4 inhibitors in patients with diabetes undergoing ...

GLP-1s are linked to a broad range of adverse events — largely gastrointestinal, metabolic, and psychological — across ...

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM. (HealthDay News) — For adults with type 2 diabetes mellitus (T2DM), glucagon-like ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia. Drawing on ...

Please provide your email address to receive an email when new articles are posted on . In patients with diabetes and major adverse limb events, GLP-1s conferred better outcomes than DPP-IV inhibitors ...